Aarti Pharmalabs Limited (AARTIPHARM.NS)
INR 577.95
(2.37%)
INR 577.95
(2.37%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 18.15 Billion | 19.45 Billion | 11.93 Billion | - | - |
| Cost of Revenue | 12.32 Billion | 11.69 Billion | 10.01 Billion | - | - |
| Gross Profit | 5.83 Billion | 7.75 Billion | 1.92 Billion | - | - |
| Operating Expenses | 3.07 Billion | 4.95 Billion | 785.66 Thousand | 45.96 Thousand | 186.75 Thousand |
| Selling, General and Administrative Expenses | 803.58 Million | 654.3 Million | 141.31 Thousand | 42 Thousand | - |
| Research and Development Expenses | 83.7 Million | 139.6 Million | 58.15 Million | - | - |
| Other Expenses | 49 Million | 23.2 Million | 15.9 Thousand | - | - |
| Cost and Expenses | 15.39 Billion | 16.65 Billion | 785.66 Thousand | 45.96 Thousand | 186.75 Thousand |
| Operating Income | 3.12 Billion | 2.81 Billion | -769.76 Thousand | -45.96 Thousand | -186.75 Thousand |
| Interest Expense | 172.14 Million | 210.5 Million | 1618.00 | - | - |
| Income Tax Expense | 835.89 Million | 672.9 Million | 331.29 Million | -46 Thousand | - |
| Earnings before Tax | 3 Billion | 2.6 Billion | -771.37 Thousand | -45.96 Thousand | -186.75 Thousand |
| Net Income | 2.16 Billion | 1.93 Billion | -771.37 Thousand | -45.96 Thousand | -186.75 Thousand |
| Earnings Per Share Basic | 23.93 | 21.35 | -0.01 | -0.18 | -0.75 |
| Earnings Per Share Diluted | 23.93 | 21.35 | -0.01 | -0.18 | -0.75 |
| Weighted Average Shares Outstanding | 90.64 Million | 90.62 Million | 90.62 Million | 250 Thousand | 249 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 90.63 Million | 90.62 Million | 90.62 Million | 250 Thousand | 250 Thousand |
| Gross Margin | 0.32 | 0.40 | 0.16 | - | - |
| EBIT Margin | 0.22 | 0.18 | -0.00 | - | - |
| Profit Margin | 0.12 | 0.10 | -0.00 | - | - |
| EBITDA | 3.9 Billion | 3.44 Billion | 2.09 Billion | 40.00 | - |
| Earnings Before Tax Margin | 0.17 | 0.14 | -0.00 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.58 Billion | 5.55 Billion | 5.05 Billion | 18.52 Billion | 4.48 Billion | 4.39 Billion |
| Cost of Revenue | 2.94 Billion | 3.97 Billion | 3.09 Billion | 12.32 Billion | 2.44 Billion | 2.52 Billion |
| Gross Profit | 1.63 Billion | 1.57 Billion | 1.96 Billion | 6.2 Billion | 2.04 Billion | 1.87 Billion |
| Operating Expenses | 910.45 Million | 815.57 Million | 977.3 Million | 3.07 Billion | 1.27 Billion | 1.17 Billion |
| Selling, General and Administrative Expenses | 910.45 Million | 815.57 Million | 977.3 Million | - | 724.3 Million | 679.6 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 22.16 Million | 20.4 Million | 49 Million | 13.9 Million | 9.8 Million |
| Cost and Expenses | 3.85 Billion | 4.79 Billion | 4.07 Billion | 15.39 Billion | 3.71 Billion | 3.69 Billion |
| Operating Income | 727.9 Million | 762.93 Million | 984 Million | 3.12 Billion | 783 Million | 708.3 Million |
| Interest Expense | 55.05 Million | 48.33 Million | 46.7 Million | 172.1 Million | 44.8 Million | 38.9 Million |
| Income Tax Expense | 171.45 Million | 182.23 Million | 305 Million | 835.9 Million | 210.6 Million | 151.5 Million |
| Earnings before Tax | 717.67 Million | 736.76 Million | 957.5 Million | 3 Billion | 738.2 Million | 669.4 Million |
| Net Income | 546.22 Million | 554.53 Million | 652.52 Million | 2.16 Billion | 527.6 Million | 518 Million |
| Earnings Per Share Basic | 6.03 | 6.12 | 7.20 | - | 5.82 | 5.72 |
| Earnings Per Share Diluted | 6.02 | 6.12 | 7.20 | - | 5.82 | 5.72 |
| Weighted Average Shares Outstanding | 90.62 Million | 90.62 Million | 90.62 Million | 90.63 Million | 90.62 Million | 90.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 90.73 Million | 90.62 Million | 90.62 Million | 90.63 Million | 90.62 Million | 90.62 Million |
| Gross Margin | 0.36 | 0.28 | 0.39 | 0.33 | 0.46 | 0.43 |
| EBIT Margin | 0.21 | 0.17 | 0.23 | - | 0.22 | 0.20 |
| Profit Margin | 0.12 | 0.10 | 0.13 | 0.12 | 0.12 | 0.12 |
| EBITDA | 981.56 Million | 964.6 Million | 1.17 Billion | - | 970.7 Million | 889.7 Million |
| Earnings Before Tax Margin | 0.16 | 0.14 | 0.19 | 0.17 | 0.17 | 0.16 |
SELAN
UNH
002162
000738
ULTP
GULFNAV